Online prescription drug platform GoodRx sell shares above IPO target range

According to a source familiar with the matter at hand, GoodRx Holdings Inc has priced its initial public offering (IPO) at $33 per share, above its target range.

The U.S.-based online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.

GoodRx did not immediately respond to requests for comments.

Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: